Google LLC’s cloud division today announced several new generative artificial intelligence solutions aimed at healthcare and life sciences aimed at enhancing data interoperability, search and improve ...

Looking back on life sciences tools & services stocks’ Q1 earnings, we examine this quarter’s best and worst performers, ...

STAMFORD, Conn.--(BUSINESS WIRE)--Technologies that enable decentralized clinical trials and other new practices are transforming the global life sciences industry, according to a new research report ...

In this week’s edition of InnovationRx, we look at breakthroughs from ASCO, Harrison.ai's U.S. expansion, Clear's move into ...

BofA Securities reports that the Life Sciences Tools sector struggled in fiscal year 2024. Spending by pharmaceutical and biotech companies dropped after pandemic-related overspending, and demand in ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. California is a national leader in innovation. This position is no more ...

The Life Sciences Research Initiative will direct $80 million annually over the next two years to fuel breakthroughs and ...

Twist Bioscience (TWST) was the only Overweight-rated stock as Piper Sandler launched its coverage of the life sciences tools sector, recommending a wait-and-see approach until the group sees its next ...

The convergence of artificial intelligence (AI) and life sciences is an emerging area of research and development with promising benefits and applications but may also have security implications. This ...

A new independent website, stephenhawking.co.uk, has launched to bring together the life, science and ideas of Stephen ...

Life sciences is standing on the edge of its most consequential decade. Scientific discovery is advancing at breakneck speed—cell and gene therapies, advanced biologics, precision diagnostics—all ...

The U.S. life sciences industry entered 2026 with surprising momentum, following threats of tariffs and disrupted trade, NIH funding cuts, and a sluggish IPO market. Accounting for more than ...